Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Dilutive issuance
confidence 75%
filed 2026-05-29
Item 1.01
The filing discloses a material amendment to an existing warrant that reduces the exercise price from $16.00 to $5.00 per share for a 90-day period, significantly increasing the likelihood and economic incentive for the warrant holder (Streeterville Capital, LLC) to exercise and acquire common stock. This dilutive modification to equity securities is material to investors assessing ownership dilution and capital structure, though the warrant itself was originally issued under a prior Securities Purchase Agreement rather than being a new issuance.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-05-29
Item 3.02
DigitalBridge issued 2,358,601 shares of class A common stock on May 28, 2026 in satisfaction of an OP unit redemption request under the Section 4(a)(2) exemption, representing a material dilutive equity issuance to an existing OP unit holder.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-05-29
Item 1.01
NeoVolta completed a registered public offering of 12,195,122 shares at $2.05 per share on May 29, 2026, raising approximately $23.5 million in net proceeds. The substantial equity issuance represents significant dilution to existing shareholders and was disclosed under Item 1.01 (Entry into a Material Definitive Agreement) via the underwriting agreement executed on May 27, 2026.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 75%
filed 2026-05-28
The filing discloses that CEO Yang Wu converted a $25.0 million convertible loan into shares of common stock on May 28, 2026. This represents a material dilutive issuance of equity securities to an insider, which would significantly affect shareholder ownership and is a material event requiring disclosure under Item 8.01. The conversion of a substantial debt instrument into equity is a classic dilutive issuance event.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 75%
filed 2026-05-28
Item 1.01
The filing discloses an amendment to a distribution agreement that extends the Company's ability to offer and sell up to $600 million in common stock shares through an at-the-market (ATM) offering program. While the amendment itself is primarily administrative (extending the expiration date and updating settlement terms), it preserves and extends a material equity issuance facility that could result in significant dilution to existing shareholders. The $600 million offering capacity represents a substantial potential dilutive issuance, making this material to investors assessing shareholder dilution risk.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 75%
filed 2026-05-28
Item 8.01
First National Master Note Trust issued $500 million in publicly offered Class A Asset Backed Notes on May 28, 2026, along with $67.3 million and $73.7 million in Class B and C notes sold to an affiliate, with net proceeds of $497.5 million used to purchase credit card receivables.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-05-28
Item 8.01
The filing discloses a registered direct offering of 8,539,709 shares of common stock at $0.5855 per share, generating approximately $5.0 million in gross proceeds. Additionally, the Company amended outstanding warrants to reduce the exercise price from a weighted average of $1.78 to $0.5855 per share, affecting 15,488,570 shares. This is a material dilutive equity issuance that would significantly affect shareholder ownership and is disclosed under Item 8.01 as a registered direct offering.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-05-28
Item 8.01
Target Hospitality entered into an underwriting agreement on May 28, 2026 for a registered public offering of 7,000,000 shares of common stock at $17.00 per share, with an additional 30-day option for 1,050,000 shares. Although the Company itself receives no proceeds (the selling stockholders are TDR Capital-controlled entities), this is a material dilutive equity issuance that increases shares outstanding and affects existing shareholders' ownership percentages. The disclosure of a registered public offering of this magnitude is material to investors.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-05-28
Item 8.01
The filing discloses an increase to the maximum aggregate offering amount under an At Market Issuance Sales Agreement (ATM offering) by $2,956,000 in common stock. This is a dilutive equity issuance that expands the company's ability to raise capital through unregistered or registered equity sales, which materially affects shareholder dilution and the company's capital structure. The company has already sold approximately $3,445,000 under the prior supplement, indicating active use of this facility.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-05-28
Item 8.01
Peabody Energy announced a private offering of $225 million in Convertible Senior Notes due 2031 to qualified institutional buyers under Rule 144A. Convertible notes are inherently dilutive securities that can be converted into equity, and a $225 million offering represents a material capital raise that would affect investor assessment of the company's capital structure and shareholder dilution risk.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 88%
filed 2026-05-28
Item 8.01
Seagate completed a privately negotiated exchange of $185.9 million in convertible notes for cash and 2,023,124 ordinary shares, a material dilutive equity issuance that reduces debt while increasing share count and affecting the company's capital structure.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-05-28
Item 3.02
CVC-PE Global Private Equity Fund disclosed an unregistered sale of limited partnership units totaling approximately $31.9 million across three classes (R-S, R-I, and C Units) on May 1, 2026, as part of its continuous private offering, exempt from Securities Act registration under Section 4(a)(2) and Regulation D.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-05-28
Item 3.02
Silver Point Specialty Lending Fund completed an unregistered private placement of 182,749 common shares for $5,000,000 pursuant to Section 4(a)(2) and Regulation D, representing a material capital raise and dilution to existing shareholders.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-05-28
Item 8.01
The disclosure describes the closing of a public offering of 14,000,000 shares of common stock on May 22, 2026, plus the exercise in full of an underwriter's option to purchase an additional 2,100,000 shares on May 26, 2026, structured through a forward sale agreement. This represents a material dilutive issuance of approximately 16.1 million shares, which would significantly affect shareholder equity and voting power. The forward sale mechanism and the company's intent to settle by May 20, 2028 confirm the dilutive nature of this capital raise.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-05-28
Item 7.01
The filing discloses the closing of a "registered direct offering" by New Horizon Aircraft Ltd. on May 27, 2026. A registered direct offering is a form of dilutive equity issuance that raises capital by selling securities directly to investors at negotiated prices, typically resulting in shareholder dilution. The announcement of the closing of this offering is material to investors assessing the company's capital structure and financing activities.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 94%
filed 2026-05-28
Item 1.01
ENDRA Life Sciences entered into a securities purchase agreement on May 27, 2026, to sell 578,387 shares of common stock and/or prefunded warrants plus warrants to purchase 1,156,774 additional shares in a private placement for approximately $3.8 million in gross proceeds, with prefunded warrants also issued to the placement agent as compensation. This unregistered equity offering under Section 4(a)(2) and Regulation D represents a significant dilutive issuance with substantial warrant overhang.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-05-28
Item 8.01
The filing discloses an increase in the maximum aggregate offering price under an At The Market (ATM) Offering Agreement by $2,661,176, in addition to approximately $6,618,059 already sold. This is a dilutive equity issuance that would materially affect shareholders through potential dilution. While the Item 8.01 disclosure also mentions acceptance into the AMD AI Developer Program, the primary material event disclosed is the ATM offering expansion.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-05-28
Item 3.02
Olenox issued unregistered Series D Preferred Stock with an aggregate stated value of $14 million, warrants, and contingent earnout shares to the sellers of CS Digital Ventures in reliance on Section 4(a)(2) and Regulation D Rule 506(b) as partial consideration for the acquisition.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-05-28
Item 3.02
Ondas Inc. completed an unregistered sale of equity securities (Shares) to non-U.S. investors under Regulation S exemption from Securities Act registration requirements. The issuance dilutes existing shareholders and signals capital-raising activity.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-05-28
Item 3.02
FreeCast issued 250,000 shares of Class A common stock on May 28, 2026, following the exercise of warrants by two accredited investors. The issuance was conducted under Section 4(a)(2) of the Securities Act and Rule 506 of Regulation D as a private placement. This represents a dilutive equity issuance to a small number of investors, which is material to shareholders as it increases share count and dilutes existing ownership stakes.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-05-28
Item 7.01
The filing discloses a "Private Placement" announced via press release on May 28, 2026, with a Securities Purchase Agreement dated May 27, 2026 attached as Exhibit 10.1. This is a classic unregistered equity issuance to private investors. For a small-cap biotech company like Polaryx Therapeutics, a private placement is material as it signals capital raising, potential dilution to existing shareholders, and the company's liquidity position.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 75%
filed 2026-05-28
Item 1.02
Hyperscale Data terminated its At-the-Market (ATM) equity offering agreement under which it had sold approximately 137.6 million shares and raised $24.7 million in gross proceeds. The substantial equity dilution from the ATM program represents a material event affecting shareholders' interests.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-05-28
NextNRG entered into a securities purchase agreement on May 25, 2026 to sell 10,000,000 shares of common stock at $0.64 per share for $6.4 million in gross proceeds in a private placement. The filing explicitly discloses this under Item 1.01 (Entry Into a Material Definitive Agreement) and Item 3.02 (Unregistered Sales of Equity Securities), relying on Section 4(a)(2) and Rule 506(d) exemptions. This is a classic dilutive private placement that would materially affect a reasonable investor's assessment of ownership dilution and capital structure.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-05-28
Sidus Space entered into a placement agency agreement on May 27, 2026 to issue 16.5 million shares of Class A common stock at $5.08 per share and 3.2 million pre-funded warrants, generating approximately $100 million in gross proceeds. This is a registered direct offering of equity securities that will dilute existing shareholders, disclosed under Item 1.01 as a material definitive agreement. The scale ($100M) and structure (direct equity issuance plus warrants) are characteristic of dilutive capital raises at small- to mid-cap companies.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-05-28
The filing discloses an unregistered private placement of 1,347,708 shares of Class A Common Stock at $0.371 per share (a 30% discount to market) to Min Gan Zhe Investment Limited under Regulation S exemption. While the filing also includes a $500,000 loan component (Item 2.03), the primary material event is the dilutive equity issuance, which represents a significant capital raise and shareholder dilution typical of small-cap financing activities.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-05-28
Item 3.02
Tamboran issued 6,537,503 shares of common stock as equity consideration in the Falcon acquisition, an unregistered issuance effected in reliance on Section 3(a)(10) of the Securities Act in exchange for outstanding securities of the acquired entities.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-05-28
Item 3.02
HPS Corporate Capital Solutions Fund completed an unregistered sale of approximately $19.54 million in common shares of beneficial interest (Class I and Class D) relying on Section 4(a)(2) and Regulations D and S exemptions, diluting existing shareholders' ownership.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-05-28
Item 3.02
CXApp Inc. issued 26.7 million shares of common stock to Avondale Capital under a Pre-Paid Purchase agreement at prices between $0.126 and $0.135 per share, relying on Section 4(a)(2) exemption for unregistered private placements. This is a classic dilutive equity issuance that would materially affect shareholder ownership and is properly disclosed under Item 3.02.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-05-27
Item 3.02
The Company issued 6,924,700 unregistered shares of common stock as earn-out consideration under a stock purchase agreement, representing approximately 4.7% dilution to outstanding shares. The issuance was made pursuant to Section 4(a)(2) and Regulation D Rule 506(b) exemptions, with recipients holding restrictive legends and lock-up agreements. This is a material dilutive equity issuance properly disclosed under Item 3.02.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-05-27
Item 1.01
BNB Plus Corp. entered into a Securities Purchase Agreement on May 26, 2026, to issue up to $5 million in convertible preferred equity securities (Series B-1 and Series B-2 Preferred Stock and related Prefunded Warrants) to accredited investors in a private placement, with an initial closing of $2.5 million. The offering includes Warrant Inducement and Exchange Agreements whereby existing investors exercise warrants and exchange common stock and pre-funded warrants for new preferred stock, materially diluting existing shareholders' ownership percentages and voting power.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-05-27
Item 3.02
Apollo Asset Backed Credit Co LLC completed unregistered sales of equity securities totaling approximately $52.6 million across Series I and Series II share classes to third-party investors, exempt under Section 4(a)(2) and Regulations D and S.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-05-27
Item 8.01
Rani entered into a securities purchase agreement on May 26, 2026, to issue 12,476,637 shares of Class A common stock and 6,214,953 pre-funded warrants for approximately $20.0 million in gross proceeds. This is a classic dilutive equity issuance to institutional investors, disclosed under Item 8.01 (Other Events). The transaction includes lock-up agreements and a 90-day lock-up on further issuances, typical of PIPE-like offerings that materially dilute existing shareholders.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-05-27
Item 3.02
Vista Credit Strategic Lending Corp. completed an unregistered sale of approximately $5.0 million in Class I and Class S common stock pursuant to subscription agreements, relying on Section 4(a)(2) and Regulations D and S exemptions.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-05-27
Item 3.02
The filing discloses an unregistered sale of equity securities (common stock) pursuant to Item 3.02, with an aggregate offering price of $29.7 million. The shares are being issued under subscription agreements to existing investors via capital calls, exempt from Securities Act registration under Section 4(a)(2) and Regulation D. This is a classic dilutive issuance of unregistered equity that would materially affect investor assessment of share ownership and capitalization.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-05-27
Item 3.02
EQT Infrastructure Company LLC disclosed unregistered sales of equity securities totaling approximately $89.8 million in Investor Shares (Class A-I, A-S, M-I, and M-S) as of May 1, 2026, plus an additional issuance of approximately 239,536 Class E Shares valued at ~$6.6 million to EQT Holdings AB on May 26, 2026. Both offerings were exempt from registration under Section 4(a)(2) and Regulations D and S. The filing explicitly states this is part of a continuous private offering that has raised approximately $539.6 million since inception on February 1, 2026, representing a material capital raise through unregistered equity issuances.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-05-27
Item 3.02
EQT Private Equity Company LLC disclosed unregistered sales of equity securities totaling approximately $28.9 million in Investor Shares (Classes A-I, A-J1, A-J2, A-S) and $58.1 million in Class E Shares to EQT Holdings AB, all exempt from registration under Section 4(a)(2) and Regulation D/S. This is a classic dilutive issuance disclosure under Item 3.02, representing continuous private offerings that have cumulatively raised approximately $746.2 million since inception in July 2025.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-05-27
Item 3.02
Stepstone Private Credit Fund LLC completed an unregistered sale of 5,680,855 LLC interests for $148.1 million pursuant to subscription agreements, relying on Section 4(a)(2), Regulation D, and/or Regulation S exemptions. This private placement raises material capital while diluting existing investors.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-05-27
Item 1.01
Q32 Bio entered into a securities purchase agreement to sell 6,725,000 shares of common stock and 150,000 pre-funded warrants to accredited investors for approximately $55 million in gross proceeds under a PIPE (private investment in public equity) transaction relying on Section 4(a)(2) exemption. The company plans to file a Registration Statement for resale of the securities.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-05-27
Item 3.02
North Haven Private Income Fund LLC completed an unregistered sale of approximately 231,644 Class S units for $4.19 million to accredited investors, relying on Section 4(a)(2) and Regulation D exemptions. This private placement represents a significant capital raise and dilution to existing unitholders.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-05-27
Item 3.02
Silver Point Private Credit Fund conducted an unregistered sale of 1,359,664 common shares for $36.4 million at $26.76 per share pursuant to subscription agreements, exempt under Section 4(a)(2) and Regulation D. This dilutive equity issuance increases share count and affects shareholder ownership.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-05-27
Item 3.02
North Haven Private Income Fund A LLC completed an unregistered sale of approximately 88,416 Class I units for $1.8 million to accredited investors, relying on Section 4(a)(2) and Regulation D exemptions. This private placement represents dilution to existing unitholders and capital raising activity.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-05-27
Item 1.01
Minerva Neurosciences entered into an at-the-market (ATM) offering agreement with Leerink Partners on May 27, 2026, authorizing the issuance and sale of up to $75.0 million in common stock shares under its S-3 registration statement.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-05-27
Item 3.02
LGAM Private Credit LLC sold approximately 394,562 Common Units for $7.7 million at $19.61 per unit pursuant to subscription agreements with unitholders, exempt from Securities Act registration under Regulation S and targeting non-U.S. persons.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 75%
filed 2026-05-27
Item 1.01
PennantPark entered into an underwriting agreement on May 27, 2026 to issue $100 million of 7.375% Notes due 2031, with an additional $15 million option. While this is technically a debt issuance rather than an equity offering, the disclosure centers on a material capital-raising transaction that would affect investor assessment of the company's capital structure and financial position. The company intends to use proceeds to repay revolving credit obligations and invest in portfolio companies, indicating material financing activity.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 94%
filed 2026-05-27
Item 1.01
La Rosa Holdings entered into a Securities Purchase Agreement on May 27, 2026, to issue up to 500 shares of Series D Convertible Preferred Stock at $1,000 per share ($250,000 closing immediately, with 250 shares optionally issuable upon filing the 2025 Form 10-K). The Series D Preferred includes conversion rights into common stock at a fixed price of $1.58 or an Alternate Conversion Price as low as 90% of 10-day VWAP, with a 125% uplift multiplier, creating significant dilution to existing shareholders.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-05-27
Item 1.01
New Horizon Aircraft entered into Securities Purchase Agreements on May 26, 2026, to sell 5,385,646 Class A ordinary shares and pre-funded warrants to purchase 4,574,514 additional shares for approximately $25.0 million in gross proceeds. The registered direct offering will result in substantial dilution to existing shareholders, with proceeds intended for Cavorite X7 prototype development and testing.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-05-27
Item 3.02
Oceanhawk issued 500,000 unregistered units to the Sponsor and The Benchmark Company, LLC at $10.00 per unit pursuant to Section 4(a)(2) of the Securities Act, generating $5 million in gross proceeds in a private placement concurrent with the IPO.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-05-27
Item 8.01
The Company entered into an equity distribution agreement with multiple underwriters to sell up to $300,000,000 of Class A common stock through an at-the-market (ATM) offering under a Form S-3ASR registration statement.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-05-27
The filing discloses entry into an At-The-Market (ATM) Issuance Sales Agreement on May 26, 2026, permitting the Company to offer and sell up to $5,000,000 of common stock through Alexander Capital. This is a classic dilutive equity issuance under Item 1.01. The forward-looking statements also reference the Company's need to regain compliance with Nasdaq's Stockholders' Equity Requirement, signaling financial stress and the use of equity issuance as a capital-raising mechanism.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 75%
filed 2026-05-27
The filing discloses issuance of a convertible promissory note for $3,052,787.68 (Item 1.01 and 3.02), which is convertible into common stock at $6.00 per share subject to stockholder approval. This is a dilutive equity issuance under Section 4(a)(2) and Regulation D. While the filing also contains a delisting notice (Item 3.01), the primary material event disclosed is the convertible note issuance, which represents a significant capital raise and potential equity dilution to existing shareholders.
View raw filing on EDGAR →